(c) 2024 PillSync.com

Dextroamphetamine saccharate amphetamine aspartate monohydrate dextroamphetamine sulfate and amphetamine sulfate Amphetamine aspartate 7.5 MG Amphetamine Sulfate 7.5 MG Dextroamphetamine saccharate 7.5 MG Dextroamphetamine Sulfate 7.5 MG Oral Ta

INDICATIONS AND USAGE Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and Narcolepsy. attention deficit hyperactivity disorder (ADHD) A diagnosis of attention deficit hyperactivity disorder (ADHD; DSM-IV ® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; "on the go;" excessive talking; blurting answers; can't wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met. Special Diagnostic Considerations Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of the required number of DSM-IV ® characteristics. Need for Comprehensive Treatment Program Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all children with this syndrome. Stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms. Long-Term Use The effectiveness of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets for long-term use has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

CorePharma, LLC


8 years ago ROUND PINK Cor 136 Dextroamphetamine saccharate amphetamine aspartate monohydrate dextroamphetamine sulfate and amphetamine sulfate  Amphetamine aspartate 7.5 MG  Amphetamine Sulfate 7.5 MG  Dextroamphetamine saccharate 7.5 MG  Dextroamphetamine Sulfate 7.5 MG Oral Ta

ROUND PINK Cor 136

8 years ago ROUND PINK Cor 136 Dextroamphetamine saccharate amphetamine aspartate monohydrate dextroamphetamine sulfate and amphetamine sulfate  Amphetamine aspartate 7.5 MG  Amphetamine Sulfate 7.5 MG  Dextroamphetamine saccharate 7.5 MG  Dextroamphetamine Sulfate 7.5 MG Oral Ta

Cor 136 ROUND PINK

HOW SUPPLIED Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, and 30 mg. Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 5 mg: blue, round, compressed tablets, debossed cor over 130 on one side and quadrisect on the other side. In bottles of 100 tablets (NDC 64720-130-10) Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 7.5 mg: blue, oval, compressed tablets, debossed cor 1 31 on one side and bisect on the other side. In bottles of 100 tablets (NDC 64720-131-10) Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 10 mg: blue, round, compressed tablets, debossed cor over 132 on one side and quadrisect on the other side. In bottles of 100 tablets (NDC 64720-132-10) Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 12.5 mg: purple, round, compressed tablets, debossed cor over 133 on one side and bisect on the other side. In bottles of 100 tablets (NDC 64720-133-10) Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 15 mg: pink, oval, compressed tablets, debossed cor 134 on one side and bisect on the other side. In bottles of 100 tablets (NDC 64720-134-10) Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 20 mg: pink, round, compressed tablets, debossed cor over 135 on one side and quadrisect on the other side. In bottles of 100 tablets (NDC 64720-135-10) Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 30 mg: pink, round, compressed tablets, debossed cor over 136 on one side and quadrisect on the other side. In bottles of 100 tablets (NDC 64720-136-10) Dispense in a tight, light-resistant container as defined in the USP. Store at 20° to 25°C (68° to 77°F). (See USP Controlled Room Temperature). Protect from moisture. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. LB# 910-01 Rev. September, 2016 Manufactured and Distributed by: CorePharma, LLC Middlesex, NJ 08846 For additional copies of the printed patient information/medication guide, please visit www.corepharma.com or call 1-800-850-2719. Corepharma logo


More pills like ROUND Cor 136












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site